IMNM
Price
$21.41
Change
-$0.93 (-4.16%)
Updated
Sep 25 closing price
Capitalization
2.43B
51 days until earnings call
Intraday BUY SELL Signals
NBP
Price
$1.38
Change
-$0.07 (-4.83%)
Updated
Sep 25 closing price
Capitalization
159.59M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs NBP

IMNM vs NBP Comparison Chart in %
View a ticker or compare two or three
VS
IMNM vs. NBP commentary
Sep 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and NBP is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
IMNM vs NBP: Fundamental Ratings
IMNM
NBP
OUTLOOK RATING
1..100
6850
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
81100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4487
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMNM's Valuation (64) in the null industry is in the same range as NBP (82). This means that IMNM’s stock grew similarly to NBP’s over the last 12 months.

IMNM's Profit vs Risk Rating (81) in the null industry is in the same range as NBP (100). This means that IMNM’s stock grew similarly to NBP’s over the last 12 months.

NBP's SMR Rating (97) in the null industry is in the same range as IMNM (98). This means that NBP’s stock grew similarly to IMNM’s over the last 12 months.

IMNM's Price Growth Rating (44) in the null industry is somewhat better than the same rating for NBP (87). This means that IMNM’s stock grew somewhat faster than NBP’s over the last 12 months.

NBP's P/E Growth Rating (98) in the null industry is in the same range as IMNM (100). This means that NBP’s stock grew similarly to IMNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMNMNBP
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 24 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 27, 2026
Stock price -- (IMNM: $21.41 vs. NBP: $1.38)
Brand notoriety: IMNM and NBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 200% vs. NBP: 1637%
Market capitalization -- IMNM: $2.43B vs. NBP: $159.59M
IMNM [@Biotechnology] is valued at $2.43B. NBP’s [@Biotechnology] market capitalization is $159.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.37B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green while NBP’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • NBP’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than NBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 4 TA indicator(s) are bullish while NBP’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 4 bullish, 6 bearish.
  • NBP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both IMNM and NBP are a bad buy in the short-term.

Price Growth

IMNM (@Biotechnology) experienced а -10.68% price change this week, while NBP (@Biotechnology) price change was -13.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.17%. For the same industry, the average monthly price growth was -13.24%, and the average quarterly price growth was +5.35%.

Reported Earning Dates

IMNM is expected to report earnings on Nov 16, 2026.

NBP is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (-4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IMNM
Daily Signal:
Gain/Loss:
NBP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XQQI51.060.29
+0.57%
NEOS Boosted Nasdaq-100 High Income ETF (XQQI)
CVMC74.110.27
+0.37%
Calvert US Mid-Cap Core Responsible Index ETF (CVMC)
DECP33.47N/A
N/A
PGIM S&P 500 Buffer 12 ETF - December (DECP)
LFAO154.56N/A
N/A
LifeX 2055 Longevity Income ETF (LFAO)
BITO11.27-0.07
-0.62%
ProShares Bitcoin ETF (BITO)

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYTX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-4.16%
KYTX - IMNM
51%
Loosely correlated
-2.58%
EDIT - IMNM
48%
Loosely correlated
-6.18%
KURA - IMNM
47%
Loosely correlated
-0.92%
VYGR - IMNM
45%
Loosely correlated
-4.29%
SLDB - IMNM
44%
Loosely correlated
-2.54%
More

NBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBP has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NBP jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBP
1D Price
Change %
NBP100%
-4.83%
VCYT - NBP
43%
Loosely correlated
-6.41%
INDP - NBP
39%
Loosely correlated
-3.75%
VSTM - NBP
36%
Loosely correlated
-0.77%
IMNM - NBP
34%
Loosely correlated
-4.16%
FHTX - NBP
34%
Loosely correlated
-2.78%
More